All regulations
Nonrulemaking
FDA
FDA-2024-E-0432
Patent Term Extension Application for LOQTORZI™ (toripalimab-tpzi), Patent No. 10,815,302
Documents
8
Comments
1
Key Dates
Comment Period OpensJan 26, 2024
Comment Period ClosesJul 30, 2025
Documents
| Type | Title | Status |
|---|---|---|
Other |
Comment Statistics
Total Comments
1
Keywords
CDER
Shanghai Junshi Biosciences Co Ltd
Junmeng Biosciences Co Ltd
Kirkpatrick Townsend and Stockton LLP
Patent Term Extension Application
for LOQTORZI™ (toripalimab-tpzi)
Patent No. 10,815,302
OPEN
Data from Regulations.gov